Publications by authors named "Colin B Erdman"

Claim this Profile
A
A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes.
Keith B Hoffman, Mo Dimbil, Robert F Kyle, Nicholas P Tatonetti, Colin B Erdman

J Manag Care Spec Pharm· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS).
Keith B Hoffman, Andrea R Demakas, Mo Dimbil, Nicholas P Tatonetti, Colin B Erdman

Drug Saf· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.
Keith B Hoffman, Mo Dimbil, Colin B Erdman, Nicholas P Tatonetti, Brian M Overstreet

Drug Saf· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-approval adverse events of new and old anticoagulants.
Keith B Hoffman, Andrea Demakas, Colin B Erdman, Mo Dimbil

BMJ· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012.
Keith B Hoffman, Andrea Demakas, Colin B Erdman, Mo Dimbil, P Murali Doraiswamy

BMJ· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis